Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Werewolf Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −2 vs. Q2 2022
- Shares held
- 21.0M
- +1.88M (+9.9%) vs. Q2 2022
- Total value
- $94.5M
- +$16.5M (+21.1%) vs. Q2 2022
- New holders
- 4
- 13 more added
- Sold out
- 6
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 88 | $0 | 0.00% | +38+76.0% | Added |
| Group One Trading, L.P. | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 80 | $0 | 0.00% | 00.0% | Unchanged |
| Glassman Wealth Services | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 12 | $0 | 0.00% | −19−61.3% | Reduced |
| China Universal Asset Management Co., Ltd. | 277 | $1.00K | 0.00% | +277 | New |
| Financial Perspectives, Inc | 250 | $1.13K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 427 | $2.00K | 0.00% | −309−42.0% | Reduced |
| Royal Bank of Canada | 387 | $2.00K | 0.00% | +154+66.1% | Added |
| Oliver Lagore Vanvalin Investment Group | 580 | $3.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,500 | $7.00K | 0.00% | −2,198−59.4% | Reduced |
| UBS Group AG | 2,450 | $11.0K | 0.00% | −1,807−42.4% | Reduced |
| Bank of America Corp | 3,478 | $15.0K | 0.00% | +784+29.1% | Added |
| Denali Advisors LLC | 5,900 | $27.0K | 0.01% | +5,900 | New |
| Tower Research Capital LLC (TRC) | 6,531 | $30.0K | 0.00% | +4,188+178.7% | Added |
| Morgan Stanley | 10,487 | $47.0K | 0.00% | −11,799−52.9% | Reduced |
| Renaissance Technologies LLC | 18,300 | $83.0K | 0.00% | +1,500+8.9% | Added |
| Northern Trust Corp | 18,553 | $84.0K | 0.00% | +4,735+34.3% | Added |
| Dynamic Technology Lab Private Ltd | 19,558 | $88.0K | 0.01% | +19,558 | New |
| Qube Research & Technologies Ltd | 19,908 | $90.0K | 0.00% | −2,627−11.7% | Reduced |
| Bailard, Inc. | 20,200 | $91.0K | 0.00% | −1,000−4.7% | Reduced |
| State Street Corp | 24,568 | $111.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 25,996 | $117.0K | 0.00% | +25,996 | New |
| Bridgeway Capital Management, LLC | 41,711 | $188.0K | 0.01% | +5,500+15.2% | Added |
| Caas Capital Management LP | 62,599 | $256.0K | 0.03% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 109,530 | $494.0K | 0.02% | −103,851−48.7% | Reduced |
| Ergoteles LLC | 114,595 | $517.0K | 0.02% | −14,405−11.2% | Reduced |
| Geode Capital Management, LLC | 120,287 | $542.0K | 0.00% | +41,007+51.7% | Added |
| BlackRock Inc. | 148,009 | $668.0K | 0.00% | −35,948−19.5% | Reduced |
| Alyeska Investment Group, L.P. | 206,201 | $930.0K | 0.01% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 246,305 | $1.11M | 0.19% | 00.0% | Unchanged |
| FMR LLC | 337,073 | $1.52M | 0.00% | −181,699−35.0% | Reduced |
| Vanguard Group Inc | 435,256 | $1.96M | 0.00% | +39,187+9.9% | Added |
| Millennium Management LLC | 511,608 | $2.31M | 0.00% | +262,691+105.5% | Added |
| Laurion Capital Management LP | 522,900 | $2.36M | 0.07% | −12,260−2.3% | Reduced |
| DC Funds, LP | 589,102 | $2.66M | 40.05% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 626,810 | $2.83M | 0.50% | +29,807+5.0% | Added |
| Deerfield Management Company, L.P. (Series C) | 958,125 | $4.32M | 0.09% | 00.0% | Unchanged |
| Rubric Capital Management LP | 966,879 | $4.36M | 0.22% | +761,883+371.7% | Added |
| Adage Capital Partners GP, L.L.C. | 1,000,597 | $4.51M | 0.01% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,388,011 | $10.8M | 2.55% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 2,815,654 | $12.7M | 0.49% | +1,084,931+62.7% | Added |
| MPM Asset Management LLC | 4,284,172 | $19.3M | 7.36% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,291,881 | $19.4M | 0.41% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,250−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,983−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,124−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −14−100.0% | Sold out |